In summary, the similar effects of gain and loss of function for both Sall4 and Bmi1 in AY-CCA suggest that BMI1 may act as a downstream effector of SALL4 in AY-CCA tumor development. The gene discussed is BMI1; the disease is cholangiocarcinoma.